EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Raia Drogasil's enterprise value is R$51,660 Mil.
Raia Drogasil's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was R$3,161 Mil. Therefore, Raia Drogasil's EV-to-EBITDA for today is 16.34.
The historical rank and industry rank for Raia Drogasil's EV-to-EBITDA or its related term are showing as below:
BSP:RADL3'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.61 Med: 20.54 Max: 192.63
Current: 16.34
During the past 13 years, the highest EV-to-EBITDA of Raia Drogasil was 192.63. The lowest was 12.61. And the median was 20.54.
BSP:RADL3's EV-to-EBITDA is ranked worse than 60.43% of 460
companies
in the Healthcare Providers & Services industry
Industry Median: 13.06
vs BSP:RADL3: 16.34
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Raia Drogasil EV-to-EBITDA Historical Data
The historical data trend for Raia Drogasil's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Raia Drogasil's EV-to-EBITDA
For the Pharmaceutical Retailers subindustry, Raia Drogasil's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raia Drogasil's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Raia Drogasil's EV-to-EBITDA falls into.
Raia Drogasil EV-to-EBITDA Calculation
Raia Drogasil's EV-to-EBITDA for today is calculated as:
Raia Drogasil's current Enterprise Value is R$51,660 Mil.
Raia Drogasil's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$3,161 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Raia Drogasil's PE Ratio for today is calculated as:
Raia Drogasil's share price for today is R$26.24.
Raia Drogasil's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0.620.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Raia Drogasil's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSP:RADL3 has been successfully added to your 